Trial Profile
Reversal of vecuronium induced residual neuromuscular block using sugammadex: a prospective, dobule-blind, randomized, controlled, dosefinding study
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 24 Sep 2017
Price :
$35
*
At a glance
- Drugs Sugammadex (Primary) ; Neostigmine
- Indications Neuromuscular blockade
- Focus Therapeutic Use
- 01 Sep 2017 Results published in the Anesthesiology
- 09 Jul 2014 New trial record